Purchase FUB-AMB

With us securely! - re-shipment guarantees.

We always offer new legal products of impeccable quality.

Please make sure that the product is legal in your country and not under control before ordering.

We do not sell pharmaceutical products or controlled products.

Where to buy FUB-AMB for sale

FUB-AMB (also known as MMB-FUBINACA) is an indazole-based synthetic cannabinoid that Pfizer originally developed; it described the compound in a patent in 2009 but was later abandoned and never tested on humans. It is a potent agonist for cannabinoid receptors and has been sold online as a designer drug. FUB-AMB was the most common synthetic cannabinoid identified in drug seizures by the Drug Enforcement Administration in 2017 and the first half of 2018.

FUB-AMB is an indazole-based synthetic cannabinoid that Pfizer originally developed in 2009 and has been sold online as a designer drug. It is a potent agonist for cannabinoid receptors.

FUB-AMB is a synthetic cannabinoid classified as an indazole-based, potent CB1 receptor agonist. It has been sold online as a designer drug.

FUB-AMB is a synthetic cannabinoid that can be classified as a designer drug.

The FDA has warned consumers not to use five drugs that Pfizer developed but never tested in humans.

FUB-AMB (also known as MMB-FUBINACA) is a potent agonist for cannabinoid receptors. Pfizer first developed it, but it was abandoned and never tested on humans. The United States Drug Enforcement Administration has identified FUB-AMB as one of the most common synthetic cannabinoids identified in drug seizures since 2017.

FUB-AMB (also known as MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist for cannabinoid receptors. It was originally developed by Pfizer, describing the compound in a patent in 2009, but it was later abandoned and never tested on humans.

FUB-AMB (MMB-FUBINACA) is an indazole-based synthetic cannabinoid that was first discovered in 2011 and was described in a scientific publication about its synthesis and receptor binding profile.

FUB-AMB (MMB-FUBINACA) is an indazole cannabinoid that was discovered in 2009. It is a potent agonist of both the CB1 and CB2 receptors with an EC50 of 0.34nM at CB1 and 0.87nM at CB2.

FUB-AMB, or MMB-FUBINACA, is a cannabinoid used as an active ingredient in synthetic cannabis products.

FUB-AMB (MMB-FUBINACA) is an antagonist for the cannabinoid receptors that compete with THC and has sedative, analgesic, muscle relaxant, neurochemical and anti-inflammatory properties.

FUB-AMB has been utilized in scientific research as an agonist.

FUB-AMB is an indazole-based synthetic cannabinoid that is a potent agonist for cannabinoid receptors and has been sold online as a designer drug. FUB-AMB is a schedule I controlled substance in the United States.

FUB-AMB (1-(4-fluorobenzyl)-1H-indole-3-carboxylic acid, is an indazole-based synthetic cannabinoid that is a potent agonist for the cannabinoid receptors and has been sold online as a designer drug. FUB-AMB is a schedule I controlled substance in the United States.

FUB-AMB(5-fluorophenyl-(indazole-3-carboxamide) is a new synthetic cannabinoid designer drug structurally similar to a series of commonly abused synthetic cannabinoids.

FUB-AMB is known for its psychoactive effects. It also has a detectable amount of naphthalene when tested.

FUB-AMB is a potent synthetic cannabinoid developed by Pfizer, and its structure differs very little from the active ingredient in cannabis. It is thought to be highly addictive and has killed users worldwide while causing severe long-term damage to others.

FUB-AMB is a synthetic cannabinoid developed by Pfizer, and its structure differs very little from the active ingredient in cannabis.

FUB-AMB, manufactured by Pfizer, was a synthetic cannabinoid developed after they studied the potent active ingredient in cannabis. Used for pain management, it resulted in addiction, death, and long-term damage to its victims.

FUB-AMB is classified as a synthetic cannabinoid and is thought to be highly addictive, and has caused severe, long-term damage to users worldwide.